Clinical Trial

Endogenous Opioid Mechanisms for Rejection Sensitivity

Study Description

Endogenous Opioid Mechanisms for Rejection Sensitivity

This project hypothesizes that the brain's opioid system determines rejection sensitivity, a personality trait that is a vulnerability factor and feature of several psychiatric disorders. This project will use positron emission tomography to measure the brain's opioid response to social rejection and acceptance in a nonclinical population with varying levels of rejection sensitivity. The results will provide the first major step towards understanding a neurotransmitter mechanism for rejection sensitivity, allowing for further investigation into predicting and treating its associated disorders.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Methods have not been listed for this study. If you require more information about the methods of this study, please inquire with the researcher.

Additional Information

Official Study Title

Endogenous Opioid Mechanisms for Rejection Sensitivity

Clinical Trial ID

NCT02189785

ParticipAid ID

0dN8Ka